A new pancreatic cancer pill may be a game changer for patients

Daraxonrasib, which nearly doubled patients’ survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.


Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top